rs17004715

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000211.5(ITGB2):​c.499+7C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0179 in 1,613,970 control chromosomes in the GnomAD database, including 500 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.035 ( 151 hom., cov: 32)
Exomes 𝑓: 0.016 ( 349 hom. )

Consequence

ITGB2
NM_000211.5 splice_region, intron

Scores

2
Splicing: ADA: 0.0009559
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.247

Publications

6 publications found
Variant links:
Genes affected
ITGB2 (HGNC:6155): (integrin subunit beta 2) This gene encodes an integrin beta chain, which combines with multiple different alpha chains to form different integrin heterodimers. Integrins are integral cell-surface proteins that participate in cell adhesion as well as cell-surface mediated signalling. The encoded protein plays an important role in immune response and defects in this gene cause leukocyte adhesion deficiency. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
ITGB2 Gene-Disease associations (from GenCC):
  • leukocyte adhesion deficiency 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 21-44903358-G-A is Benign according to our data. Variant chr21-44903358-G-A is described in ClinVar as Benign. ClinVar VariationId is 340172.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0804 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ITGB2NM_000211.5 linkc.499+7C>T splice_region_variant, intron_variant Intron 5 of 15 ENST00000652462.1 NP_000202.3 P05107A0A494C0X7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ITGB2ENST00000652462.1 linkc.499+7C>T splice_region_variant, intron_variant Intron 5 of 15 NM_000211.5 ENSP00000498780.1 A0A494C0X7

Frequencies

GnomAD3 genomes
AF:
0.0345
AC:
5252
AN:
152080
Hom.:
152
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0828
Gnomad AMI
AF:
0.00439
Gnomad AMR
AF:
0.0202
Gnomad ASJ
AF:
0.0173
Gnomad EAS
AF:
0.0529
Gnomad SAS
AF:
0.0182
Gnomad FIN
AF:
0.00602
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0141
Gnomad OTH
AF:
0.0301
GnomAD2 exomes
AF:
0.0213
AC:
5359
AN:
251192
AF XY:
0.0199
show subpopulations
Gnomad AFR exome
AF:
0.0842
Gnomad AMR exome
AF:
0.0118
Gnomad ASJ exome
AF:
0.0151
Gnomad EAS exome
AF:
0.0635
Gnomad FIN exome
AF:
0.00730
Gnomad NFE exome
AF:
0.0136
Gnomad OTH exome
AF:
0.0192
GnomAD4 exome
AF:
0.0161
AC:
23603
AN:
1461772
Hom.:
349
Cov.:
32
AF XY:
0.0159
AC XY:
11588
AN XY:
727202
show subpopulations
African (AFR)
AF:
0.0872
AC:
2919
AN:
33478
American (AMR)
AF:
0.0123
AC:
552
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0160
AC:
417
AN:
26134
East Asian (EAS)
AF:
0.0525
AC:
2085
AN:
39698
South Asian (SAS)
AF:
0.0143
AC:
1233
AN:
86254
European-Finnish (FIN)
AF:
0.00794
AC:
424
AN:
53414
Middle Eastern (MID)
AF:
0.0191
AC:
110
AN:
5768
European-Non Finnish (NFE)
AF:
0.0131
AC:
14529
AN:
1111918
Other (OTH)
AF:
0.0221
AC:
1334
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
1315
2630
3946
5261
6576
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
632
1264
1896
2528
3160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0345
AC:
5257
AN:
152198
Hom.:
151
Cov.:
32
AF XY:
0.0340
AC XY:
2527
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.0827
AC:
3431
AN:
41506
American (AMR)
AF:
0.0202
AC:
309
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0173
AC:
60
AN:
3470
East Asian (EAS)
AF:
0.0530
AC:
274
AN:
5166
South Asian (SAS)
AF:
0.0178
AC:
86
AN:
4820
European-Finnish (FIN)
AF:
0.00602
AC:
64
AN:
10626
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0141
AC:
959
AN:
67990
Other (OTH)
AF:
0.0298
AC:
63
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
241
483
724
966
1207
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0220
Hom.:
64
Bravo
AF:
0.0380
Asia WGS
AF:
0.0340
AC:
117
AN:
3478
EpiCase
AF:
0.0149
EpiControl
AF:
0.0145

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 16, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Leukocyte adhesion deficiency 1 Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
7.9
DANN
Benign
0.46
PhyloP100
0.25
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00096
dbscSNV1_RF
Benign
0.030
SpliceAI score (max)
0.18
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17004715; hg19: chr21-46323273; API